The Department of Health and Human Services cut over $750 million in funding for Moderna to develop an mRNA bird flu vaccine for humans.
The Biden administration awarded the vaccine manufacturer a $590 million grant in January from the Biomedical Advanced Research and Development Authority. The funding followed another $176 million award for an mRNA-based H5N1 avian influenza vaccine that HHS granted Moderna in July 2024.
Real journalism.Trusted by millions.
Unlimited access to in-depth reporting, expert analysis, and the stories that shape our country.
Subscribe Now
Already a member? Log in
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.